Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Confirmatory Study of AMG 162 (Denosumab) in Patients With Rheumatoid Arthritis on DMARDs Treatment (Phase III)

NCT01973569 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT01973569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01973569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Confirmatory Study of AMG 162 (Denosumab) in Patients With Rheumatoid Arthritis on DMARDs Treatment (Phase III)
Lead sponsor
Daiichi Sankyo
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
September 19, 2017
Enrollment
679 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis